Patent · US Active

Selective estrogen receptor degraders

US10654866B2 · kind B2 · utility

5Cited by

2References

19Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Jolie Anne Bastian · Indianapolis, US
Jeffrey Daniel Cohen · Indianapolis, US
Almudena Rubio · Carmel, US
Daniel Jon Sall · Greenwood, US

Key dates

Filing date	Jul 11, 2019
Grant date	May 19, 2020
Priority date	—
Expiry date	Jul 11, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel selective estrogen receptor degraders (SERDs) according to the formula: pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein either R1 or R2 is independently selected from Cl, F, —CF3, or —CH3, and the other is hydrogen, and methods for their use are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.